Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Sirona Biochem Corp > Working for the V's
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1354)
•••
Comment by Pandoraon Sep 09, 2024 1:13am
123 Views
Post# 36214226

RE:RE:RE:Working for the V's

RE:RE:RE:Working for the V's
Pandora wrote:
lscfa wrote: Christopher Verrico ceased to be an insider Nov 27, 2013. Damn fool must have filed an incorrect insider report or SBM has hired him back as a director and not disclosed it yet.


From the "Ownership" tab near the top of the page:

 
  Date
 
 
 Name
 
 
 Shares Traded
 
 
 Value
 
 
 Shares Held
 
 
 Filing Type
 
 
 
2024-03-11
Verrico (Christopher R)
16,000
.00
1,574,539
SEDI
 
2024-02-19
Verrico (Howard)
450,000
.00
9,855,695
SEDI
 
 
Verrico (Howard)
--
.00
--
 

From the "Insiders" tab near the top of the page:

  Date
 
 
 Name
 
 
 Shares Traded
 
 
 Value
 
 
 Shares Held
 
 
 Filing Type
 
 
 
2024-03-11
Verrico (Christopher R)
16,000
.00
1,574,539
SEDI
 
2024-02-19
Verrico (Howard)
450,000
.00
9,855,695
SEDI
 
 
Verrico (Howard)
--
.00
 

It seems strange there is nothing since March of 2024 and it also seems strange there is nothing for Chris Hopton.

I have no idea how or how often Stockhouse gets this data updated.


Funny how we only have 3 individuals regarding insider ownership and two of them are named Christopher.

Also a little strange that Geraldine is not mentioned --- but again I must admit I have no idea how Stockhouse gets this data.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities